BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29450198)

  • 1. Parvovirus B19: What Is the Relevance in Transfusion Medicine?
    Juhl D; Hennig H
    Front Med (Lausanne); 2018; 5():4. PubMed ID: 29450198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
    Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
    Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
    Juhl D; Görg S; Hennig H
    Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.
    Yu MY; Alter HJ; Virata-Theimer ML; Geng Y; Ma L; Schechterly CA; Colvin CA; Luban NL
    Transfusion; 2010 Aug; 50(8):1712-21. PubMed ID: 20158689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus b19 infections and blood counts in blood donors.
    Juhl D; Steppat D; Görg S; Hennig H
    Transfus Med Hemother; 2014 Feb; 41(1):52-9. PubMed ID: 24659948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
    Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
    PeerJ; 2023; 11():e15698. PubMed ID: 37554334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.
    Kleinman SH; Glynn SA; Lee TH; Tobler LH; Schlumpf KS; Todd DS; Qiao H; Yu MY; Busch MP;
    Blood; 2009 Oct; 114(17):3677-83. PubMed ID: 19687508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine.
    Adamo MP; Blanco S; Viale F; Rivadera S; Rodríguez-Lombardi G; Pedranti M; Carrizo H; Gallego S
    Heliyon; 2020 May; 6(5):e03869. PubMed ID: 32395652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the risk, cost-effectiveness, and perceived benefits of anti-parvovirus B19 tested blood products.
    van Hoeven LR; Janssen MP; Lieshout-Krikke RW; Molenaar-de Backer MW
    Transfusion; 2019 Jul; 59(7):2352-2360. PubMed ID: 31032994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
    Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
    J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
    Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
    J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil.
    Slavov SN; Otaguiri KK; Covas DT; Kashima S
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):323-5. PubMed ID: 27408426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic parvovirus B19 infection caused by blood component transfusion.
    Satake M; Hoshi Y; Taira R; Momose SY; Hino S; Tadokoro K
    Transfusion; 2011 Sep; 51(9):1887-95. PubMed ID: 21332725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.
    Lee TH; Kleinman SH; Wen L; Montalvo L; Todd DS; Wright DJ; Tobler LH; Busch MP;
    Transfusion; 2011 Sep; 51(9):1896-908. PubMed ID: 21303368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-Derived Human Parvovirus B19 Infection in Kidney Transplantation.
    Yu Y; Wei C; Lyu J; Wu X; Wang R; Huang H; Wu J; Chen J; Peng W
    Front Cell Infect Microbiol; 2021; 11():753970. PubMed ID: 34722340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England.
    Williams S; Ratcliff J; Nguyen D; Simmonds P; Harvala H;
    Transfus Med; 2022 Oct; 32(5):402-409. PubMed ID: 35751630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
    Molenaar-de Backer MW; Russcher A; Kroes AC; Koppelman MH; Lanfermeijer M; Zaaijer HL
    J Clin Virol; 2016 Nov; 84():19-23. PubMed ID: 27664778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the human parvovirus B19 biology.
    Servant-Delmas A; Morinet F
    Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.